Abbott FreeStyle Libre 3 FreeStyle Libre 3 System Next-Gen CGM performance you can count on Now with the smallest, thinnest1 and most discreet2 sensor yet Readings3 are updated 5x faster than other CGMs4 Outperforms other CGMS in connectivity5 Unsurpassed 14-day accuracy, especially in the low glucose range6 Optional, real-time glucose alarms let patients know the minute their glucose is too low6 Performance you can count on With a CGM system that sends real-time glucose readings every minute directly to your patients' smartphones,7 they will be ready to avoid hypos Unsurpassed accuracy 9.2% Overall MARD6 (Adults) and Unsurpassed 14-day accuracy, especially in the low glucose range6 with 93.2% within ±20/20% of YSI values for glucose levels <80 mg/dL and ±20% when ≥80 mg/dL6. No data gaps Now the sensor can store data up to 14 days. So no data gaps means your patients can always retrieve their data even when their smartphone has not synced with their sensor for up to 14 days. Proven clinical outcomes A1c was reduced by 0.55% at 2 to 4 months and sustained for 12 months8 and 50% reduction in serious hypoglycaemia (≤54 mg/dL).9

Mispa HbX Portable Haemoglobin Analyzer Overview Mispa HbX , Smart Haemoglobin analyzer is a symbol of advanced point of care equipment with modern technology and convenience, designed to deliver high accuracy, quality results with least turnaround time and low maintenance. Best in Class Hemoglobin Meter Mispa HbX, the Smart Haemoglobin Analyzer, is the best example of an advanced point-of-care hemoglobin reader with modern technology. It is easy to use and designed to deliver accurate, high-quality results with the shortest turnaround time and minimal maintenance. This digital Hb meter is one of the best hemoglobin meters available. Working of A Hemoglobin Meter or a hemoglobin reader A hemoglobin meter or a hemoglobin reader measures the amounts of hemoglobin and hematocrit in whole blood. Hemoglobin tests are typically performed to determine the RBC count, the severity of anemia, hematocrit, and other haematological factors. It is widely utilized during blood donations and key decisions such as blood transfusions. HbX works with Spectrophotometry Scattered compensation Technology for accurate and quick results Results will be retrieved with in less than 3 seconds after sample reading starts Sample Required: 7ul Capillary or Venous blood Three Step procedure makes HbX more convenient to use CV value will be less than 1.5 % 6 Hours Battery Backup makes it a hand equipment 2000 Data storage capacity Micro Fluidic cuvettes with 2 year Shelf life

INTENDED USE The Finecare™ Vitamin D Rapid Quantitative Test along with Finecare™ FIA Meter is a fluorescence immunoassay quantitative determination of total 25(OH) D2/D3 level in human serum or plasma. Results are to be used in conjunction with other clinical and laboratory data to assist the clinician in the assessment of vitamin D sufficiency. STORAGE AND STABILITY 1. Store at 4°C～30°C up to the expiration date. 2. The solid marker bottle can be stored at 2°C～8°C for 28 days after being reconstituted. 3. Do not remove the device from the pouch until ready to use. The Test Cartridges should be used within 1 hour once opened.

The BC-3600 Hematology analyzer features closed tube sampling via a single push button. A built-in large 10.4 inch color touchscreen allows maximum visibility. Hemoglobin analysis is performed using cyanide-free reagent. The analyzer processes up to 60 samples per hour and stores up to 40,000 results with histograms. The barcode reader and optional LIS connectivity enable seamless sample data transmission. Nearly all scheduled maintenance procedures are automated by touch buttons. The intuitive software enhances workflow efficiency and provides operators with a pleasant user experience. Key Features CBC plus 3-part differential, 16 parameters + 3 histograms 60 samples per hour, 1 min per CBC Closed tube sampling, minimize operational biohazard Built In diluent dispenser for predilution mode All-in-one CBC result screen display; results at a glance Touch button maintenance procedures One maintenance reagent only – probe cleaner Storage capacity of 40,000 results with histograms Uploadable QC files; ensure accuracy and time efficiency Parameters WBC, Lymph#, Mid#, Gran#, Lymph%, Mid%, Gran%, RBC, HGB, HCT,MCV, MCH, MCHC, RDW,PLT, MPV and histograms for WBC, RBC, PLT Principles Electrical impedance method for cell counting and Cyanide - free for hemoglobin Sample Volume Prediluted 20µL Whole Blood 21µL Carryover WBC/RBC/HGB≤0.5% PLT≤1.0% Connectivity 4 USB ports (for external printer, software upgrade, barcode reader,keyboard and mouse), LAN port (1), RS232 (1) Printout Thermal recorder, 50mm width paper, various printout formats, external printer (optional) Product Specification Brand Mindray Differential Type 3-Part Model Name/Number BC 3600 Display Type Large color touch screen Resolution 800x600 Usage/Application Hospital Throughput 60 samples per hour Power Supply AC 100-240V,50/60 +-1Hz Weight 62 lbs Dimension 16 in(W) x 18 in(H) x 18 in(D) Humidity 30%-85% Temperature 15 ~30 Deg C Minimum Order Quantity 1

Since the company was founded, Mindray has been continuously exploring new ways to improve diagnostic confidence. Powered by the most revolutionary ZONE Sonography® Technology, Resona 7’s new ZST+ platform brings ultrasound image quality to a higher level by zone acquisition and channel data processing. As well as the premium level image quality, Resona 7 also enhances clinical research capabilities with the revolutionary V Flow for vascular hemodynamic evaluation, and the most intelligent plane acquisition from 3D datasets for fetal CNS diagnosis. Combining the most intuitive gesture-based multi-touch operation and all the essential clinical features, Resona 7 is truly leading new waves in ultrasound innovation. With core platform advantages of ZST+ The channel data based ZST+ is an extraordinary innovation, representing an ultrasound evolution. Transforming ultrasound metrics from conventional beamforming to channel data based processing, ZST+ is able to deliver multiple imaging advances: Advanced Acoustic Acquisition, Dynamic Pixel Focusing, Sound Speed Compensation, Enhanced Channel Data Processing and Total Recall Imaging. Advanced features V Flow V Flow (Vector Flow) is a novel approach for vascular hemodynamic analysis. V Flow uses color coded vector arrows to indicate the velocity’s magnitude and direction of blood cells. With ultra-high frame rates, it provides extremely accurate and angle-independent visualization of complex vascular hemodynamic profiles. With comprehensive data information, V Flow is the most valuable tool for vascular clinical research. resona-7-fig3-1-pc UWN+ Contrast Imaging UWN+ (Ultra-Wideband Non-linear Plus) CEUS enables the Resona 7 to detect and utilize both the 2nd harmonic and non-linear fundamental signals, generating significantly enhanced images, resulting in greater sensitivity of minor signals and longer agent duration with lower MI. Forwarding smart to clinical intelligence The Resona 7 elevates clinical intelligence with a complete solution that enables clinicians to manage both routine and advanced studies more efficiently,consistently, and accurately, from acquisition to calculation. As an example, Smart Planes CNS shows exceptional intelligence in accurate diagnosis and analysis of the fetal central nervous system (CNS) Smart Planes CNS Mindray’s exclusive pioneering technology positions the Resona 7 as the industry’s first ultrasound system to allow fully automatic and accurate detection of the most significant planes and frequently used measurements of fetal CNS, leading to intelligent diagnosis, improved throughput, and reduced user dependence. Smart Planes CNS provides a user-friendly tool that greatly improves scanning efficiency through increased accuracy coupled with automated operation. With a simple button click on a 3D fetal brain volume image, the standard CNS scanning planes (MSP, TCP, TTP and TVP) and a range of related anatomical measurements (BPD, HC, OFD, TCD, CM and LVW) are obtained immediately. Smart Face Acquiring an optimal view of the fetal face in 3D ultrasound is cumbersome and time-consuming. In some cases, it is impossible to get rid of the occlusions such as cord, placenta, uterus and extremities. The new Resona 7 with Zone Intelligence provides a fast and intelligent optimization for fetal face with simply one-touch. It can immediately remove occlusions in the volume data, eliminate unwanted noise information, and generate an optimal view of the fetal face with minimal effort. Ergonomics The Resona 7 is designed around you. Gesture-based operation opens up a new trend in cart-based ultrasound with an agile, smart, and intuitive user experience beyond your expectations. Gel warmer’s three level temperature and swiveling angle adjustment of the control panel delivers great patient comfort and user convenience.

In compliance with out-of-hospital patient transport standards such as EN1789, EN13718-1, IEC60601-1-12 and U.S. military standards, N1 is a highly competent solution for various out-of-hospital transport settings both on land and in air. The N1's exceptional reliability and strong performance enhance your confidence to provide seamless patient care during transport no matter intra or out of hospital. One monitor, Multiple solutions Mirror Mode Two-way screen or remote control functionality and viewing on both the 19" external display and the N1 unit - simultaneously. benevision-n1-fig2-2-pc BeneVision N1 as a Transport Monitor Enhanced data analysis greatly improves parameters' accuracy and anti-interference ability. Its fully integrated sidestream CO2 module monitors the patient's breathing situation by connecting with sampling line directly, freeing caregivers from the shackles of expanding external modules for transport. One monitor, Multiple solutions Mirror Mode Two-way screen or remote control functionality and viewing on both the 19" external display and the N1 unit - simultaneously. benevision-n1-fig2-2-pc BeneVision N1 as a Transport Monitor Enhanced data analysis greatly improves parameters' accuracy and anti-interference ability. Its fully integrated sidestream CO2 module monitors the patient's breathing situation by connecting with sampling line directly, freeing caregivers from the shackles of expanding external modules for transport. benevision-n1-fig2-1-pc BeneVision N1 as a Multi-Parameter Module Slide directly into the module slot or SMR of the N-Series monitor providing an expansive set of parameter measurements. When combined with our additional advanced parameter modules, this solution fits even the highest level of critical care environments. benevision-n1-fig2-3-pc Companion Mode Connect with N-Series host monitor via cable connection to N1 dock and have the ability for dual-screen monitoring and bi-directional control of the bedside monitor - expanding slot space for more advanced parameters and enhanced ICU workflow. Patient-Centric Data Collection When connected to a bedside patient monitor, advanced parameters collected from the host monitor such as AG and BIS, etc., will also be stored in N1 with trend data and alarm events reviewable even when it is disconnected.

With state-of-the-art screen technology, BeneVision N Series patient monitors deliver clear, multi-color, wide-format displays for users to capture and review information at a glance. With multi-touch operation, users can control the monitor and review patient data quickly and easily. BeneVision N Series provides the world's best monitoring technologies for you, with new applications being developed. Perfect hemodynamic monitoring solution, not only provides a variety of measurement methods, ICG, PiCCO, ScvO2, C.O., but also provides comprehensive analysis tool – HemoSight™. HemoSight™ focuses on hemodynamic treatment process, and provides appropriate tools for each stage. Advanced modular regional tissue oxygenation measurement -- INVOS rSO2. Volumetric capnography & metabolic measurement help to evaluate the adequacy of ventilation and determine the ventilator setting effectively, and improve the safety of weaning and extubation. Powerful Clinical Assistive Applications (CAAs) to support efficient decision making when time is critical. Each CAA focuses on major clinical workflow challenges that individual departments face. Solutions optimized for each point of care At every point of care, such as ICU, CCU, NICU, OR, PACU, ER, BeneVision N Series patient monitors always provide a suitable solution to meet your clinical needs for monitoring your patient's status anywhere, anytime, even on your way through mobile devices. With excellent transport solution, BeneVision N Series patient monitor brings a smooth workflow and safe data management through the entire care process. BeneVision takes less time to operate, and helps you understand the patient's variables quickly. With HL7,BeneVision N Series patient monitors can directly connect to the hospital clinical network.BeneVision N12 is capable of monitoring multiple parameters simultaneously both at bedside and during transport. IT structure designed for seamless connectivity Mindray patient monitoring system incorporates extensive network adaptability to integrate with the hospital's current network infrastructure, ensuring that critical data is on hand for clinical decision making - and is integrated with the patient record. Mindray's central station and eGateway further enhances the connectivity of BeneVision to your clinical world. Bedside devices data and other clinical systems data are shared to support your diagnosis and clinical decisions.

Mindray believes the best way to predict the future is to create it. The revolutionary BeneVision N22/N19 is designed to optimize user experience by satisfying all your clinical demands. With visionary-stimulating design, benchmarking ease of use, confidence-maximizing innovations and workflow-transforming interoperability, BeneVision N22/N19 is creating tomorrow’s monitoring perspective today. The design excellence of BeneVision N22/N19 has great originality to lead your perspective. A seamless outlook optimizes your monitoring experience with super large touchscreen, cool rotatable landscape & portrait layout, ultra slim main unit as well as plug-n-play modules. An ingenious user interface including multi-window flat menus, infographic alarm indications and online user guide offers extremely intuitive patient data and ultimate ease-of-use, while auto screen brightness always keeps patient in mind. Benefitting from cutting-edge clinical measurements, such as rSO2, ICG, PiCCO, AG, RM, BIS, NMT, and state-of-art clinical decision support tools, such as HemoSightTM, ST GraphicTM, DSA, BeneVision N22/N19 enhances your clinical confidence to the max and helps you make easier and faster clinical decisions. The connectivity capabilities of BeneVision N22/N19 fit seamlessly into your clinical workflow for paperless future. Revolutionary iView clinical informatics workstation brings all intelligence (PACS, LIS, EMR, etc) on screen at point of care for one-stop diagnosis. Industry-leading BeneLink integrates all bedside devices to the monitor realtimely and facilitates centralized data management.

The OnSite hCG Combo Rapid Test is a lateral flow chromatographic immunoassay for the early detection of pregnancy, by providing a quick direct visual test for the placental hormone, hCG in human serum, plasma and urine. It can be performed within 5-10 minutes by minimally skilled personnel, and without the use of laboratory equipment. The OnSite hCG Combo Rapid Test is not intended for quantitative results, nor for over the counter (OTC) sales. It is intended to meet all requirements for yielding rapid, easily read, qualitative results for the purpose of early pregnancy detection via assay of hCG, a placental hormone that may be present in human serum, plasma or urine. The hCG detection limit the OnSite hCG Combo Rapid Test is 12.5 mIU/mL in serum or plasma specimen, and 25 mIU/mL in urine specimen. It is designed for professional use only, and provides only preliminary analytical data. For a final diagnosis of pregnancy, a more specific alternative clinical method must be used to obtain a confirmed analytical result. Clinical accuracy: In comparison with a reference chemiluminecsence or ELISA, hCG detection is 100% sensitivity and 100% specificity in urine specimens 100% sensitivity and 99.5% specificity in serum specimens Analytical sensitivity: 100% positive detection rate at 12.5 mIU/mL in serum/plasma specimens and 100% positive detection rate at 25 mIU/mL in urine specimens Analytical specificity: no cross reactivity with 1,000 mIU/mL human luteinizing hormone (hLH), 1,000 mIU/mL human follicle stimulating hormone (hFSH), and 1,000 mIU/mL human thyroid stimulating hormone (hTSH) Dose hook effect: no dose hook effect was observed for hCG at concentrations up to 500,000 mIU/mL in urine specimens Interference: No interference was seen with 35 biological and chemical analytes commonly found in OTC, prescriptions or abuse drugs in urine or serum/plasma specimens, as well as pH 4-9 (see detail in the package insert) Shelf life: 24 month Kit box package: 1. Individually sealed foil pouches containing; a. One dip strip device b. One desiccant 2. One package insert (instruction for use) Tube package: 1. Strip Package 2. One desiccant 3. One package insert (instruction for use) CTK Products at a Glance Drugs.com: Overview of Human Chorionic Gonadotropin Inserts